PLoS Medicine (Mar 2019)
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
Abstract
In a Collection Review, Patrick Phillips and colleagues discuss developments in clinical trial design for the evaluation of TB therapeutics.